These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Status of a group B Neisseria meningitidis vaccine. Frasch CE Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731 [No Abstract] [Full Text] [Related]
3. Vaccines against meningococcal meningitis: current status. Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300 [No Abstract] [Full Text] [Related]
4. [Vaccines against Neisseria meningitidis]. Ferrón L; Criado MT; Ferreirós CM Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002 [No Abstract] [Full Text] [Related]
5. Vaccines for prevention of meningococcal disease. Frasch CE Clin Microbiol Rev; 1989 Apr; 2 Suppl(Suppl):S134-8. PubMed ID: 2497956 [No Abstract] [Full Text] [Related]
6. [Meningococcal disease in the Netherlands; after low tide another high tide?]. Zanen HC Ned Tijdschr Geneeskd; 1984 Mar; 128(11):515-8. PubMed ID: 6424036 [No Abstract] [Full Text] [Related]
7. Bacterial outer membrane protein vaccines. The meningococcal example. Poolman JT Adv Exp Med Biol; 1996; 397():73-7. PubMed ID: 8718585 [No Abstract] [Full Text] [Related]
8. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. Noronha CP; Struchiner CJ; Halloran ME Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439 [TBL] [Abstract][Full Text] [Related]
9. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development. Jennings HJ Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499 [No Abstract] [Full Text] [Related]
13. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis]. Xu CH Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030 [No Abstract] [Full Text] [Related]
14. [Immune response to meningococci]. Flaegstad T Tidsskr Nor Laegeforen; 1989 Jan; 109(1):33-6. PubMed ID: 2492123 [TBL] [Abstract][Full Text] [Related]
15. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report. Lepow ML; Gold R N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865 [No Abstract] [Full Text] [Related]
16. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa]. Chippaux JP; Debois H; Saliou P Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963 [TBL] [Abstract][Full Text] [Related]
17. Development of a meningococcal vaccine. Poolman JT Infect Agents Dis; 1995 Mar; 4(1):13-28. PubMed ID: 7728353 [No Abstract] [Full Text] [Related]
18. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic]. Wu C Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683 [No Abstract] [Full Text] [Related]
19. [African aspects of vaccination in prevention of purulent meningitis]. Rey M Ann Soc Belg Med Trop; 1980 Sep; 60(3):237-52. PubMed ID: 6788000 [No Abstract] [Full Text] [Related]
20. [Interpretation of the laboratory results concerning the protective effect of vaccines]. Berrón Morato S; Sanz Moreno JC; Martín García E; Salcedo Peláez C; Bermúdez Saugar MP; Vázquez Moreno JA Rev Esp Salud Publica; 1998; 72(5):431-3. PubMed ID: 9951337 [No Abstract] [Full Text] [Related] [Next] [New Search]